129 related articles for article (PubMed ID: 11840103)
1. Clinical outcome in chordoma: utility of flow cytometry in DNA determination.
Berven S; Zurakowski D; Mankin HJ; Gebhardt MC; Springfield DS; Hornicek FJ
Spine (Phila Pa 1976); 2002 Feb; 27(4):374-9. PubMed ID: 11840103
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
5. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
[TBL] [Abstract][Full Text] [Related]
6. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of DNA content measured by flow cytometry in supraglottic laryngeal carcinoma].
Morales Angulo C; Fernández Fernández F; Val Bernal F; Buelta L; García-Castrillo L; Rama Quintela J
Acta Otorrinolaringol Esp; 1997; 48(6):483-6. PubMed ID: 9471196
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes.
Akiyama T; Ogura K; Gokita T; Tsukushi S; Iwata S; Nakamura T; Matsumine A; Yonemoto T; Nishida Y; Saita K; Kawai A; Matsumoto S; Yamaguchi T
Ann Surg Oncol; 2018 Apr; 25(4):912-919. PubMed ID: 29181683
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors.
Radio SJ; Wooldridge TN; Linder J
Hum Pathol; 1988 Jan; 19(1):74-7. PubMed ID: 2826327
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hürthle cell neoplasms of the thyroid.
McLeod MK; Thompson NW; Hudson JL; Gaglio JA; Lloyd RV; Harness JK; Nishiyama R; Cheung PS
Arch Surg; 1988 Jul; 123(7):849-54. PubMed ID: 3382350
[TBL] [Abstract][Full Text] [Related]
16. Soft tissue vascular tumors. A flow cytometric DNA analysis.
Fukunaga M; Shimoda T; Nikaido T; Ushigome S; Ishikawa E
Cancer; 1993 Apr; 71(7):2233-41. PubMed ID: 8453543
[TBL] [Abstract][Full Text] [Related]
17. [Malignancy of hepatocellular carcinoma evaluated with nuclear DNA ploidy pattern].
Kamiyama T; Uchino J; Une Y; Ishizu H
Nihon Rinsho; 1992 Oct; 50(10):2408-12. PubMed ID: 1333017
[TBL] [Abstract][Full Text] [Related]
18. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of sacral chordoma: survival and prognostic factors.
Ruosi C; Colella G; Di Donato SL; Granata F; Di Salvatore MG; Fazioli F
Eur Spine J; 2015 Nov; 24 Suppl 7():912-7. PubMed ID: 26458933
[TBL] [Abstract][Full Text] [Related]
20. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
